EP3679062 - T CELL RECEPTORS THAT BIND TO MIXED LINEAGE LEUKEMIA (MLL)-SPECIFIC PHOSPHOPEPTIDES AND METHODS OF USE THEREOF [Right-click to bookmark this link] | Status | Grant of patent is intended Status updated on 25.02.2024 Database last updated on 22.08.2024 | |
Former | Examination is in progress Status updated on 12.01.2024 | ||
Former | Grant of patent is intended Status updated on 12.06.2023 | ||
Former | Examination is in progress Status updated on 14.05.2021 | ||
Former | Request for examination was made Status updated on 12.06.2020 | ||
Former | The international publication has been made Status updated on 08.03.2019 | ||
Former | unknown Status updated on 15.10.2018 | Most recent event Tooltip | 18.07.2024 | New entry: Application deemed to be withdrawn: despatch of communication + time limit | Applicant(s) | For all designated states MiNK Therapeutics, Inc. 149 Fifth Avenue, Suite 500 New York, NY 10010 / US | [2023/43] |
Former [2020/29] | For all designated states Agenus Inc. 3 Forbes Road Lexington, MA 02421 / US | Inventor(s) | 01 /
VAN DIJK, Marc Tolhuislaan 8A 3735 KG Bosch en Duin / NL | 02 /
BREOUS-NYSTROM, Ekaterina Vladimirovna Waldenburgerstrasse 15 4052 Basel / CH | 03 /
FRANCHINO, Alessandra Luzernerring 124 4056 Basel / CH | 04 /
LALEVÉE, Sébastien 5 Rue des Cerisiers 68300 Saint Louis / FR | 05 /
HURWITZ, Arthur Andrew 9 Fitchdale Avenue Bedford Massachusetts 01730 / US | 06 /
EXLEY, Mark Adrian 201 Reservoir Road Chestnut Hill MA 02467 / US | 07 /
WOLF, Benjamin Jacob 478 Jamaicaway B Boston MA 02130 / US | [2020/29] | Representative(s) | Simmons & Simmons LLP (Munich), et al Lehel Carré Thierschplatz 6 80538 Munich / DE | [N/P] |
Former [2020/29] | Lahrtz, Fritz Patentanwälte Isenbruck Bösl Hörschler PartG mbB Prinzregentenstraße 68 81675 München / DE | Application number, filing date | 18782236.6 | 04.09.2018 | [2020/29] | WO2018US49397 | Priority number, date | US201762553957P | 04.09.2017 Original published format: US 201762553957 P | [2020/29] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019046856 | Date: | 07.03.2019 | Language: | EN | [2019/10] | Type: | A1 Application with search report | No.: | EP3679062 | Date: | 15.07.2020 | Language: | EN | The application published by WIPO in one of the EPO official languages on 07.03.2019 takes the place of the publication of the European patent application. | [2020/29] | Search report(s) | International search report - published on: | EP | 07.03.2019 | Classification | IPC: | A61K38/00, A61K45/06, A61P35/00, C07K14/705, C07K14/725, C12N9/10 | [2023/24] | CPC: |
C07K14/7051 (EP,KR,US);
C12N5/0636 (KR);
A61K38/00 (EP,KR,US);
A61K45/06 (EP,KR,US);
A61P35/00 (EP,KR);
C07K14/70503 (EP,KR);
C12N15/63 (US);
C12N9/1007 (EP,KR);
C12Y201/01008 (KR);
|
Former IPC [2020/29] | C07K14/705, C07K14/47 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/29] | Extension states | BA | 03.04.2020 | ME | 03.04.2020 | Validation states | KH | 03.04.2020 | MA | 03.04.2020 | MD | 03.04.2020 | TN | 03.04.2020 | Title | German: | T-ZELL-REZEPTOREN, DIE AN MIXED LINEAGE LEUKEMIA(MLL)-SPEZIFISCHE PHOSPHOPEPTIDE BINDEN, UND VERFAHREN ZUR VERWENDUNG DAVON | [2020/29] | English: | T CELL RECEPTORS THAT BIND TO MIXED LINEAGE LEUKEMIA (MLL)-SPECIFIC PHOSPHOPEPTIDES AND METHODS OF USE THEREOF | [2020/29] | French: | RÉCEPTEURS DE LYMPHOCYTES T QUI SE LIENT À DES PHOSPHOPEPTIDES SPÉCIFIQUES DE LA LEUCÉMIE DE LIGNÉE MIXTE (MLL) ET MÉTHODES D'UTILISATION DE CES DERNIERS | [2020/29] | Entry into regional phase | 03.04.2020 | National basic fee paid | 03.04.2020 | Designation fee(s) paid | 03.04.2020 | Examination fee paid | Examination procedure | 03.04.2020 | Examination requested [2020/29] | 03.04.2020 | Date on which the examining division has become responsible | 27.01.2021 | Amendment by applicant (claims and/or description) | 17.05.2021 | Despatch of a communication from the examining division (Time limit: M06) | 28.02.2022 | Reply to a communication from the examining division | 16.08.2022 | Despatch of a communication from the examining division (Time limit: M04) | 23.12.2022 | Reply to a communication from the examining division | 13.06.2023 | Communication of intention to grant the patent | 12.01.2024 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 26.02.2024 | Communication of intention to grant the patent | 17.07.2024 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time | Request for further processing for: | The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent | 12.01.2024 | Request for further processing filed | 12.01.2024 | Full payment received (date of receipt of payment) Request granted | 22.01.2024 | Decision despatched | The application is deemed to be withdrawn due to failure to reply to the examination report | 28.02.2022 | Request for further processing filed | 28.02.2022 | Full payment received (date of receipt of payment) Request granted | 09.03.2022 | Decision despatched | 27.01.2021 | Request for further processing filed | 27.01.2021 | Full payment received (date of receipt of payment) Request granted | 03.02.2021 | Decision despatched | Fees paid | Renewal fee | 30.03.2021 | Renewal fee patent year 03 | 27.09.2021 | Renewal fee patent year 04 | 27.09.2022 | Renewal fee patent year 05 | 27.09.2023 | Renewal fee patent year 06 | Penalty fee | Additional fee for renewal fee | 30.09.2020 | 03   M06   Fee paid on   30.03.2021 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [IY]WO2011149909 (HUNT DONALD F [US], et al) [I] 1-170 * table 2B; sequences 166, 229 * * paragraph [0047] * * example 1 * [Y] 1-170; | [Y]WO2017044672 (AGENUS INC [US]) [Y] 1-170 * examples 3, 5, 6 * * paragraph [0059] *; | [Y] - M. COBBOLD ET AL, "MHC Class I-Associated Phosphopeptides Are the Targets of Memory-like Immunity in Leukemia", SCIENCE TRANSLATIONAL MEDICINE, US, (20130918), vol. 5, no. 203, doi:10.1126/scitranslmed.3006061, ISSN 1946-6234, pages 203ra125 - 203ra125, XP055532798 [Y] 1-170 * the whole document * * figures 4a, c, e * DOI: http://dx.doi.org/10.1126/scitranslmed.3006061 | [ ] - M. COBBOLD ET AL, "MHC Class I-Associated Phosphopeptides Are the Targets of Memory-like Immunity in Leukemia", SCIENCE TRANSLATIONAL MEDICINE, US, (20130918), vol. 5, no. 203, doi:10.1126/scitranslmed.3006061, ISSN 1946-6234, pages 203ra125 - 203ra125, XP055532847 [ ] * the whole document * * figures S2, S3, S6 * DOI: http://dx.doi.org/10.1126/scitranslmed.3006061 | [XP] - C. Plewa ET AL, "Discovery of phospho-peptide neoantigen tumor targets (PTTs) and identification of novel T cell receptors (TCRs) targeting phospho-MLL for adoptive cell therapy AgenTus Therapeutics: differentiated cell therapy", (20180831), URL: http://www.agentustherapeutics.com/wp-content/uploads/2018/09/AgenTus-PTT_MLL-Poster-2018_0831-FINAL.pdf, (20181211), XP055532797 [XP] 1-170 * the whole document * | by applicant | DE1370147 | WO9618105 | US5580714 | US5807715 | US5965726 | WO9957268 | WO0031239 | US6174666 | US6291664 | US6383492 | US6391306 | US6403095 | US6410026 | US6414132 | US6436404 | US6447780 | US6447781 | WO03020763 | US6610659 | US6645495 | US2003232323 | US2004014194 | WO2004033685 | US6740484 | US6794498 | US6808710 | US2005048549 | US7029678 | US7052906 | US7329731 | US7332582 | US7488802 | WO2010005958 | US2010203056 | US7858589 | WO2011044186 | US7943743 | US8008449 | US8114845 | US8168757 | US8168179 | US8217149 | US8354509 | US8361794 | WO2013033091 | US2013202623 | WO2013126712 | US8552154 | US2013291136 | US2013323249 | WO2014022758 | US2014044738 | US8686119 | WO2014055897 | US8735553 | US8747847 | WO2014100079 | US8779105 | US8779108 | WO2014179664 | US2014341917 | US2014356363 | US8906383 | WO2014209804 | WO2014206107 | US8927697 | US8981063 | WO2015036394 | US8993731 | WO2015058573 | WO2015061668 | WO2015085847 | US2015203580 | WO2015109124 | US9089520 | US9102727 | US2015225483 | WO2015123527 | US9175082 | US2015346208 | US9205148 | US2015355184 | WO2015195163 | WO2015200119 | WO2016000619 | WO2016015685 | WO2016020856 | WO2016030350 | US2016075783 | - COBBOLD et al., Sci Transl Med., (20130918), vol. 5, no. 203, page 203ral25 | - LEFRANC, The Immunologist, (19990000), vol. 7, pages 132 - 136 | - LEFRANC et al., Nucleic Acids Res, (19990000), vol. 27, pages 209 - 212 | - LEFRANC et al., Dev Comp Immunol., (20030000), vol. 27, no. l, pages 55 - 77 | - SAVAGE et al., Immunity, (19990000), vol. 10, no. 4, pages 485 - 492 | - GIEGE R et al., Acta Crystallogr D Biol Crystallogr, (19940000), vol. 50, pages 339 - 350 | - MCPHERSON A, Eur J Biochem, (19900000), vol. 189, pages 1 - 23 | - CHAYEN NE, Structure, (19970000), vol. 5, pages 1269 - 1274 | - MCPHERSON A, J Biol Chem, (19760000), vol. 251, pages 6300 - 6303 | - Meth Enzymol, (19850000), vol. 114-115 | - BRICOGNE G, Acta Crystallogr D Biol Crystallogr, (19930000), vol. 49, pages 37 - 60 | - BRICOGNE G, Meth Enzymol, (19970000), vol. 276A, pages 361 - 423 | - Acta Crystallogr D Biol Crystallogr, (20000000), vol. 56, pages 1316 - 1323 | - CHAMPE M et al., J Biol Chem, (19950000), vol. 270, pages 1388 - 1394 | - CUNNINGHAM BC; WELLS JA, Science, (19890000), vol. 244, pages 1081 - 1085 | - KARLIN S; ALTSCHUL S, PNAS, (19900000), vol. 87, pages 2264 - 2268 | - KARLIN S; ALTSCHUL SF, PNAS, (19930000), vol. 90, pages 5873 - 5877 | - ALTSCHUL SF et al., J Mol Biol, (19900000), vol. 215, page 403 | - ALTSCHUL SF et al., Nuc Acids Res, (19970000), vol. 25, pages 3389 - 3402 | - MYERS; MILLER, CABIOS, (19880000), vol. 4, pages 11 - 17 | - KOPYTEK, S J. et al., Chemistry & Biology, (20000000), vol. 7, pages 313 - 321 | - GESTWICKI, J. E. et al., Combinatorial Chem. & High Throughput Screening, (20070000), vol. 10, pages 667 - 675 | - CLACKSON T, Chem Biol Drug Des, (20060000), vol. 67, pages 440 - 442 | - COBBOLD et al., Sci Transl Med., (20130918), vol. 5, no. 203, page 203ra125 | - RAO et al., Nat Rev Cancer, (20150600), vol. t5, no. 6, pages 334 - 346 | - LI et al., Exp Hematol., (20141200), vol. 42, no. 12, pages 995 - 1012 | - KRIVTSOV et al., Nat Rev Cancer, (20071100), vol. 7, no. 11, pages 823 - 833 | - DWORNICZAK; MIRAULT, Nucleic Acids Res., (19870000), vol. 15, pages 5181 - 5197 | - "GenBank", Database accession no. P11142 | - HUNT; MORIMOTO, Proc. Natl. Acad. Sci. U.S.A., (19850000), vol. 82, no. 19, pages 6455 - 6459 | - "GenBank", Database accession no. PODMV8 | - "GenBank", Database accession no. Ml 1717 | - KUTMEIER G et al., BioTechniques, (19940000), vol. 17, pages 242 - 246 | - Current Protocols in Molecular Biology, Green Publishing Associates. Inc. and John Wiley & Sons, Inc., (19890000), vol. I, pages 6.3.1 - 6.3.6 | - FOCCKING MK; HOFSTETTER H, Gene, (19860000), vol. 45, pages 101 - 105 | - COCKETT MI et al., Biotechnology, (19900000), vol. 8, no. 7, pages 662 - 667 | - RUETHER U; MUELLER-HILL B, EMBO J, (19830000), vol. 2, pages 1791 - 1794 | - INOUYE S; INOUYE M, Nuc Acids Res, (19850000), vol. 13, pages 3101 - 3109 | - VAN HEEKE G; SCHUSTER SM, J Biol Chem, (19890000), vol. 24, pages 5503 - 5509 | - LOGAN J; SHENK T, PNAS, (19840000), vol. 81, no. 12, pages 3655 - 3659 | - BITTER G et al., Methods Enzymol., (19870000), vol. 153, pages 516 - 544 | - WIGLER M et al., Cell, (19770000), vol. 11, no. 1, pages 223 - 232 | - SZYBALSKA EH; SZYBALSKI W, PNAS, (19620000), vol. 48, no. 12, pages 2026 - 2034 | - LOWY I et al., Cell, (19800000), vol. 22, no. 3, pages 817 - 823 | - WIGLER M et al., PNAS, (19800000), vol. 77, no. 6, pages 3567 - 3570 | - O'HARE K et al., PNAS, (19810000), vol. 78, pages 1527 - 1531 | - MULLIGAN RC; BERG P, PNAS, (19810000), vol. 78, no. 4, pages 2072 - 2076 | - WU GY; WU CH, Biotherapy, (19910000), vol. 3, pages 87 - 95 | - TOLSTOSHEV P, Ann Rev Pharmacol Toxicol, (19930000), vol. 32, pages 573 - 596 | - MULLIGAN RC, Science, (19930000), vol. 260, pages 926 - 932 | - MORGAN RA; ANDERSON WF, Ann Rev Biocheni, (19930000), vol. 62, pages 191 - 217 | - NABEL GJ; FEIGNER PL, Trends Biotechnol, (19930000), vol. 11, no. 5, pages 211 - 215 | - SANTERRE RF et al., Gene, (19840000), vol. 30, no. 1-3, pages 147 - 156 | - COLBERE-GARAPIN F et al., J Mol Biol, (19810000), vol. 150, pages 1 - 114 | - BEBBINGTON CR; HENTSCHEL CCG, The use of vectors based on gene amplification for the expression of cloned genes in mammalian cells in DNA cloning, Academic Press, (19870000), vol. 3 | - CROUSE GF et al., Mol Cell Biol, (19830000), vol. 3, pages 257 - 266 | - ZHAO Y, J Immunol, (20070000), vol. 179, pages 5845 - 5854 |